An international reach project that verifies the security and the effectiveness of a a new potential therapeutic approach for FSH Distrofy




Muscular dystrophies are a group of muscle diseases caused by mutations in different genes which cause loss of function, reduction or absence of protein necessary for muscular stability. The consequences are gradual weakening of muscular tissue and strength deficit that can vary on seriousness, distribution and moment of appearance.

Facio-Scapulo-Humeral Dystrophy (FSHD) is the most frequent genetic muscular disease after Duchenne muscular dystrophy and Steinert myotonic dystrophy: 1 in 8,000 individuals, or 870,000 people worldwide. FSHD strikes men, women, and children of all races and ethnicities. Ten percent develop symptoms before age 10. The condition is inherited and can affect many family members across generations.

Typically beginning in early teenage years with the loss of muscles in the face (facio), shoulders (scapula), upper arms (humerus), legs or core, FSHD can spread to any muscle. The disease has been associated to a particular structure, in the final region of the chromosome 4, established by a reduced number of DNA elements repeated in sequence. Differently from other diseases, an alteration/absence of whichever protein does not correspond to the reduced size of that particular zone of the chromosome 4, since that region does not codify for any protein, generally.

Latest news

Your practical guide to clinical trials
Your practical guide to clinical trials

by Amanda Hill, FSHD Society How do I find clinical trials that are recruiting participants? Our website is one of...

 Phase 3 trial of Losmapimod, the voice of NeMO Milano
Phase 3 trial of Losmapimod, the voice of NeMO Milano

The interview is edited by Maria Giovanna Tortora for the FSHD Group of UILDM. When will the trial start? The...

Two live webinars for patients and clinicians
Two live webinars for patients and clinicians

Taking charge of people with FSHD. Treatment, prospects and therapeutic opportunities. Two live webinars dedicated to patients and health professionals...



FSHD Society

FSHD Alliance

FSHD Global

FSHD Europe

Treat NMD

Copyright © 2022 UILDM.ORG All rights reserved, site created by AM TEK SRL.